Xeris Biopharma Holdings, Inc. XERS Other intangible assets—net
Other intangible assets—net at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s other intangible assets—net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s other intangible assets—net?
- Xeris Biopharma Holdings, Inc. (XERS) reported other intangible assets—net of $85.37M in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s other intangible assets—net changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s other intangible assets—net decreased by 11.3% year-over-year, from $96.21M to $85.37M.
- What does other intangible assets—net mean?
- This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.